Home/Lazurite/Dr. Mark Froimson
DM

Dr. Mark Froimson

Chair and CEO

Lazurite

Therapeutic Areas

Lazurite Pipeline

DrugIndicationPhase
ArthroFree 2 SystemArthroscopic and Endoscopic VisualizationCommercial
ArthroFree for Endoscopy ClinicsClinic-based Endoscopic Procedures (e.g., ENT)Commercial